....

Similar documents
ADHD LD ITPA K ABC DSM ADHD LD MBD WISC K ABC ITPA 62

TDM研究 Vol.23 No.1

97-00


釧路市幼児教育振興計画(完成版).doc

untitled


障害者職域拡大カリキュラム研究会中間報告書構成案

 

untitled

Poket Manual H4_H1_130306

Development 2

Taro13-04.ガイドライン【1部~

Taro13-ADHDガイドブック最終

AJISAI10-1.PDF

FU-20α2無停電電源装置取扱説明書

2 3

表紙4_1/山道 小川内 小川内 芦塚


本文/宮川充司先生

Vol



スライド タイトルなし

橡後藤弁護士プレゼンメモ.doc


38

「諸雑公文書」整理の中間報告

untitled

untitled

NPO 9 26

,g,g,g,9g

y=ax y=ax y=ax

2

untitled

No.193 ( HPhttp:// htmL)

2!! 1 2

各科診療科長

【1】医薬品・医療機器等安全性情報 No

....._...i2006.N.x.j.ren

.{...qxd

<91E63989F182A482C295618A7789EF8FB4985E8F575F E696E6464>

....


199004_渓仁会_年次報告書



縺・・縺。謔縲・シ冗ャャ・難シ仙捷

untitled

2016_H1-H4_コーフ<309A>き<3099>ふCSR報告書.indd


レイアウト 1

NEWS_158.qxd

2016年度予算要望書

24 RS 24 RSRespiratory Syncytial Virus RS BPD24 24CHD RS RS BPD CHD

中小企業サポ115号.indd

pt % =1 1

表1-表4宅建99.indd

表1-表4宅建98.indd

表1-表4宅建101.indd

表1-表4宅建いわて-表紙.indd

1 川崎市長マニフェスト評価研究報告書表紙

橡Taro11-報告書0.PDF

財務情報

10

8 8 0

生活設計と金融・保険に関する調査 VOL.6




20 NPO

NEWS_160.qxd

() () () () kcal/100g /100g /100g () mg/100g mg/100g g/100g 100 DHA DHA


1

食道がん化学放射線療法後のsalvage手術


FAQ 2

レジャー産業と顧客満足の課題


untitled

Microsoft Word - 表紙資料2-4

食事編_表1_4_0508

.....I.v.{..


‚䔃OK

HP・図書リスト( ).xlsx

000ŒÚ”Ł

28Łª”q-11…|…X…^†[

「個人をどう捉えるか」で変わる教育シーン

untitled

untitled


J-D Lounge

橡長沼事件関係資料_041002_.PDF

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _

まとめ原稿9-1



発達障害を知る

Transcription:

2 Vol. 20 No. 101998

Vol. 20 No. 101998 3

ADHD Attention-Deficit/Hyperactivity Disorder 104.5 13 4 Vol. 20 No. 101998

1920 1930 1937 DSMDiagnostic and Stastical Manual of Mental Disorders,Fourth Edition WHOICD10International Classification of Diseases,Tenth Edition DSM ADHD ICD10 DSM MBDMinimal Brain Dysfunction LDLearning Disabilities MBD Soft Neurological Sign LD Vol. 20 No. 101998 5

6 Vol. 20 No. 101998

ADHD 4090 3050 ADHD positive spike WISCRWechsler Inteligent Scale for Child 1025 ITPAIlinois Test of Psycholinguistic Abilities ADHD Vol. 20 No. 101998 7

8 Vol. 20 No. 101998 3070 ADHD carbamazepine haloperidol methylphenidate dextro-amphethaminepemoline 20mg/

9 Vol. 20 No. 101998 48ADHD ADHD ADHD 37

10 Vol. 20 No. 101998 ADHD90 ADHD LD FDA 30 40

11 Vol. 20 No. 101998 10

12 Vol. 20 No. 101998 10 Citrobacter Ballerup 20635 24.9114.0 g/g 24.967.2g/g36.7114.0g/g 24.049.3 g/g 20 14 0.20.3g/g 20g/g 600g/g

13 Vol. 20 No. 101998 1991 131.5 P.zeylanica Peh 40 19891022Mt Fuji 1985 1989

Biosphere 1993 5 No.6 14 Vol. 20 No. 101998

1 QOL QOL QOL coping 60707090 Vol. 20 No. 101998 17

27 11 22 4 65 14 28 4 70 80 65 90 60 70 60 80 NLP 20 41 NLPSST 20 20 NLPFT 21 19 NLPSSTFT 20 0 1987 Blankenburg 1982 noncompliant McGhie & Chapman1961 Dawson & Nuechterlin 1984 1994 Grossman L & Summers F198020 60 15 18 Vol. 20 No. 101998

19 Vol. 20 No. 101998 1998 1996 1995 MOOK 1989 MYW1997 1997 1998 1996 R. P. 1993

80 90 20 90 51 50 ICD10F20. X 22 BPRSDIEPSS QOL 63318551995 161163 1995 50951419011996 9610321994 Johnson DAWObservation no the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia. J. Clin. psychiatry 45 (5)13211984 Hogaty GE, Andeson CM, Reiss DJ et al Famity Psychoeducation, Social Skills, and maintenance Chemotherapy in Aftercare Treatment of Schizoprenia. Arch Gen psychiatry 436336421986 p52611998 9810051996 9810051996 20 Vol. 20 No. 101998

,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, T.Theorell 1937 Theorell Vd Kel Theorell Vol. 20 No. 101998 21

22 Vol. 20 No. 101998 Vd Vd t1/2 t1/2 1.11426 1966 Bishoff

23 Vol. 20 No. 101998 HIV 2001000mg X tx Xt t

t Xt dx/dt Kel dx KelX dt dx/dt dx/dty y=ax X XXe Kelt e Kelt 2,700 Vd XVdC XXe Kelt VdCVdCe Kelt Vd CCe Kelt 1.1 C Ct C 3.0ng/ml X100 e Kelt e Kelt e Kelt e 2.718Kel 24 Vol. 20 No. 101998

e Kelt CCe Kelt C e Kelt e Kelt C e Kelt e Kelt Fac accumulation factor e Kelt Css.max e Kelt e Kelt e Kelt Css.maxVd Dosee Kel FS 1.2 1.3 1.4 S Kel DoseCss.maxVd/FS e Kel F 1001.0S 1001.0 Css.maxVd FS Css.maxVd/FS Dose DI Dose Css.max Vd F Vol. 20 No. 101998 25

1998.10 Drug Information 1996.12 The 3rd Edition of Michael E. Winters BASIC CLINICAL PHARMACOKINETICS Applied TherapiuticsInc. 11 12 123000 50 86 10 50 26 Vol. 20 No. 101998

ZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZ 86 72 365 18 Vol. 20 No. 101998 29

2.5 2T T. T 74 1/2T O2 Y. Y 92 L10 1T 25 3T 90100/5060 QOL O. K 73 25 2T 1/2T 1T L20 2T R 2P 3T 100 3P 30 3T 2.5 6T 1T 4T 0.5 1T TTS K. M 70 S 2.0 2.0 3T 3T 100 4T-- 250 4T-- 2T 10 30 Vol. 20 No. 101998

H. M 83 S 2.0 2P 25 2T 20 2T 2.5 6T 100 3P 100 3T 1.9 K. T 73 23 1 2 3 1 2 3 MSWPTOT 14 14 Vol. 20 No. 101998 31

32 Vol. 20 No. 101998 QOL PTOT PT OTMSW QOL ADL QOL

581619 Vol. 20 No. 101998 33

25220 10 1926 20 712 Zanthoxylum xanthos xylon piperitum Japanease PepperPoivre japonais Zanthoxylum piperitum De Candolle 15 3.5 34 Vol. 20 No. 101998

Z. piperitum DC. f. inrme Makino 1928 Z. piperitum DC. f. Z. piperitum DC. f. brevispinum Makino Z. armatum DC. var. subtrifoliatum Kitam. Z. alatum Roxb. var. pianispinum Rehd. et E. H. Wils. Z. planispinum Sieb. ex Zucc. m 10 1961 No.1239 Fagara mantchurica Honda Z. schnifolium Sieb. et Zacc. Vol. 20 No. 101998 35

g No.1240 Z. bungeanum Maxim. m limonene 1997 1995 tt Z. simulans Hance m 10 m Citoronellaldllimonener--Phellandrene GeraniolCitronellol --Sanshoöl --Sanshoöl-- Hydroxy--Sanshoöl-- Hydroxy--Sanshoöl -Sanshoölall-trans-Sanshoöl QuercitrinAfzelinHesperidin 36 Vol. 20 No. 101998

gg Vol. 20 No. 101998 37

27 ADL 85 14 97 85 19 1021 Vol. 20 No. 101998 39

85 9697 97 40,80 30,70375.3 9,45923.26391.6 100 15 1029 22 40 Vol. 20 No. 101998

18 10 11 94 79 10 10 11 417079 Vol. 20 No. 101998 41

NPO 12) 12 non-profit-organizationimidas 98 NPO NPONPO 42 Vol. 20 No. 101998

PL 1 Clinical Pharmacy 1960 2 Vol. 20 No. 101998 43

3 10305 14547.5 7825.5 12 3.9 7022.9 4 5 1218 44 Vol. 20 No. 101998

45 Vol. 20 No. 101998 300 33.839.713.2 7.04.0 97 QOL 10 11 12

71.4 13.3 14.7 72.4 11.0 16.5 65.1 10.3 24.3 62.1 11.8 25.7 71.3 7.4 21.3 78.7 7.0 14.0 40.8 23.5 35.7 74.6 5.5 19.9 73.5 7.7 18.4 72.8 7.7 33.1 77.1 6.3 15.8 75.4 5.5 18.4 48.1 13.9 36.8 75.4 7.3 16.5 64.7 12.5 21.3 300 40.8 46 Vol. 20 No. 101998

117 30 Vol.20, No.5, 21998 Vol.31, No.10, 12201995 Vol.46, No.10, 14651994 1986 Vol.19, No.9, 91997 Vol. 20 No. 101998 47

From Kuraya Drug Information Center 48 Vol. 20 No. 101998

Vol. 20 No. 101998 49

50 Vol. 20 No. 101998

Vol. 20 No. 101998 51

52 Vol. 20 No. 101998

Vol. 20 No. 101998 53

^ 10/ 10/21 600 6103-3499-3388 1,000 103-3785-3858 FAX03-3787-1325 2-2-1 1 10/17 11/28 10,000 1 Vol. 20 No. 101998 55

56 Vol. 20 No. 101998 18 1874 800 600 500 1045 400660 200250 300400 600 10 11 300 30059 35 12 20 130 25

57 Vol. 20 No. 101998 450500 44 500 100 520 2635 100200

19 26 27 30 102728 49!! 30 TO SEE IS TO BELIVE 58 Vol. 20 No. 101998

E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D Vol. 20 No. 101998 61

62 Vol. 20 No. 101998 NaN3 LDL046mg/kg LDL030mg/kg LDL035mg/kg LD50 18mg/kg LDL012mg/kg 0.65 1.3mg0.01 0.02mg/kg 1015 30 0.653.9mg 15 NaNa CNKCNNaCN HCNLDL00.57mg/kg 50100mg KCN150200mg NaCN200300mg KCNNaCNHCN 5,000 100% 1530/ Na Na10ml 25Na50ml10 25KGNa

63 Vol. 20 No. 101998 10mg/kg 10 Na125ml10 Na 10 As4AsO3AsCl3AsH3 AsO3LD501.43mg/kg 60120mg AsH3TDL00.11mgAs/kg SH 3060 12 10 70 Mg30g 200mlP BAL100mg/A 2.5mg/kg10Na10ml g Na5g 1996 1977 133981998 1990 1991 37 LDL0 LD50 50 TDL0

64 Vol. 20 No. 101998 20 mg 30mg 498 15 300 130 301030 10 11 10 12 18 19 20 21 22 23 26

65 Vol. 20 No. 101998 13 14 151026 16 1812 1910 20 21 22 23 24 25 107,883 24 Q&A 28 18 27 14 5212flecainidflecainido 14flubiprofenflurbiprofen 5312 15399392 14FU UF 13142442 11 5412 5612methimazolethiamazole

101030 66 Vol. 20 No. 101998 31 10 ADHD 102010373 300 101-0054 1 21 132940271 2,000 YMCA YMCA JR